Articles by: Geisel Communications

Solutions Emerging for Post-GLP-1 Weight Regain—Medscape

Read article—Quotes Shelby Sullivan, a professor of medicine, as the lead author of a study evaluating a novel endoscopic procedure to prevent weight regain after patients discontinue GLP-1 weight-loss medications. “What’s particularly encouraging is that the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response,” said Sullivan.

Landmark Pancreatic Cancer Treatment Paves Way for Targeting Other Tricky Tumors—Scientific American

Read article—Features Michael Cole, a professor of molecular and systems biology, in an article examining new approaches to targeting MYC, a cancer-driving protein long considered “undruggable.” The article highlights a breakthrough pancreatic cancer drug targeting RAS proteins and reports that Cole is investigating compounds that could block MYC’s ability to activate certain other genes involved in tumor growth.  (Similar coverage in MisrYoum.)

5 Ways To Reduce Everyday Exposure to ‘Forever Chemicals’—NPR

Read article—Features Megan Romano, an associate professor of epidemiology, discussing the health risks associated with PFAS, or “forever chemicals,” which are commonly found in drinking water, food, and consumer products. “They have really unique properties, and that’s part of what has made them so attractive to industry. Unfortunately, we’re learning that it is also something that makes them toxic and causes problems in the human body,” Romano said.

Why Young Men Are Killing Their Sperm—Vox

Read article—Features Ugis Gruntmanis, a professor of medicine, discussing the fertility risks associated with testosterone therapy amid rising use of the hormone among young men. Gruntmanis said that while testosterone can suppress sperm production, “the effect is reversible once patients stop taking testosterone,” though it can take time for normal sperm production to return.

Landmark Cancer Trial Shows Success Against ‘Undruggable’ Cancer — Raising Hopes for Future Treatments—Nature

Read article—Features Michael Cole, a professor of molecular and systems biology, in an article on new approaches to targeting MYC, a cancer-driving protein long considered “undruggable.” The article reports that Cole is investigating compounds that could block MYC’s ability to activate genes involved in tumor growth following a breakthrough pancreatic cancer trial targeting RAS proteins.

The Next Pandemic Will Come From A Conflict Zone—Foreign Policy

Read article—An op-ed co-authored by Daniel Lucey, a clinical professor of medicine, argues that the latest Ebola outbreak in the Democratic Republic of the Congo and Uganda exposes major weaknesses in the global pandemic preparedness system, particularly in conflict zones. “These emergencies persist not because the world lacks scientific knowledge, but because conflict, inequity, collapsing vaccination systems, and political fragility continue to erode the foundations of public health,” the co-authors write. (Similar coverage in World Socialist Web Site.)

Valley Parents column: Give children the freedom to play—Valley News

Read article—A parenting column by Miriam Voran, a clinical assistant professor of psychiatry, discusses the importance of unstructured play in children’s emotional and social development, including for their mental health. “Through play, children practice emotion regulation, self-control, social skills and problem-solving,” says Voran. “Play is a child’s work; it’s their path to growth.”

Skin Cancer: Know the Risks, Types and Treatments—New Hampshire Union Leader

Read article—Quotes Shane Chapman, Matthew Davis, and Matthew LeBoeuf, faculty in the Department of Dermatology, in a three-part series on preventing and treating melanoma and other forms of skin cancer as summer approaches. New Hampshire’s older population, lighter skin and hair types, and concentrated sun exposure contribute to elevated skin cancer risk, Chapman said. Additional stories in this series are here and here.